the study's lead author and a professor of radiology in the University of Pennsylvania Perelman School of Medicine, said in a statement that the findings were "observational" and do not "definitively confirm an association between GLP-1 medications and reduced breast cancer incidence," however the study "does add to the growing body of evidence suggesting that it's worth investigating these weight-loss drugs as potential cancer prevention tools." Narula reiterated that the new study is "hypothesis-generating" not "practice-changing," though the study does add to a growing body of similar research
Concept for a unidirectional release mucoadhesive buccal tablet for oral delivery of antidiabetic peptide drugs such as insulin, glucagon-like peptide 1 (GLP-1), and their analogs
[1] [2] The primary indications remain type 2 diabetes mellitus and obesity management in carefully selected patients
And with easy dosing options and monthly visits, getting started has never been easier
After emergency surgery, follow the same post-operative protocol: wait for clearance, resume gradually, and contact your prescriber if side effects feel unusual during recovery